FDA Announces Pilot Program for CMC Changes

Drug Industry Daily
A A
The FDA is seeking participants for a pilot program to help the agency define specific established conditions (ECs) for chemistry, manufacturing and controls in applications for NDAs, ANDAs and BLAs.

To View This Article:

Login

Subscribe To Drug Industry Daily